Syncom Formulations

Syncom Formulations (India) Ltd, established in 1955, is a prominent entity within the Pharmaceuticals and Healthcare sectors. The company specializes in pharmaceutical formulation and development, placing a strong emphasis on stringent regulatory compliance to uphold high-quality standards across its product portfolio. Its operational focus is on delivering reliable pharmaceutical solutions, catering to a diverse clientele that includes both international and domestic markets. Syncom Formulations aims to solidify its position as a significant player in the pharmaceutical industry through continuous innovation in its products and services.

Operating with a workforce of 500 - 1,000 employees, Syncom Formulations generates an annual revenue of $31.5M. The company maintains a presence across 3 distinct locations, underscoring its operational footprint. This scale of operation supports its commitment to developing and delivering pharmaceutical products. For insights into the individuals driving these initiatives, one can explore Meet Syncom Formulations's team. The company's strategic direction is geared towards expanding its market reach and enhancing its product offerings within the competitive healthcare landscape.

The company's product range encompasses essential healthcare and pharmaceutical formulations, with a consistent focus on quality assurance and development. Syncom Formulations leverages its expertise to serve clients seeking dependable pharmaceutical solutions, contributing to the broader healthcare ecosystem. Its strategic objectives include fostering innovation and maintaining a competitive edge through adherence to global quality benchmarks and effective market penetration strategies. The company's ticker symbol is BSE: 524470.